| |
| |
|
| Insider
Information: |
Mandelia Ashish |
| Relationship: |
VP, Chief Accounting O... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
23,328 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$80,715 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
23,328 |
|
|
| Total
Value |
$80,715 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mersana Therapeutics, Inc. |
MRSN |
VP, Chief Accounting O... |
2024-01-16 |
23,328 |
2020-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRSN |
Mersana Therapeutics, Inc... |
VP, Chief Accounting Officer |
• – – |
2024-01-16 |
4 |
AS |
$2.71 |
$13,618 |
D/D |
(5,025) |
23,328 |
0 |
% |
|
| MRSN |
Mersana Therapeutics, Inc... |
VP, Chief Accounting Officer |
• – – |
2024-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,352 |
28,353 |
0 |
- |
|
| MRSN |
Mersana Therapeutics, Inc... |
VP, Chief Accounting Officer |
• – – |
2024-01-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,783 |
23,001 |
0 |
- |
|
| MRSN |
Mersana Therapeutics, Inc... |
VP, Chief Accounting Officer |
• – – |
2024-01-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,645 |
18,218 |
0 |
- |
|
| MRSN |
Mersana Therapeutics, Inc... |
VP, Controller |
• – – |
2023-01-17 |
4 |
S |
$5.74 |
$20,521 |
D/D |
(3,575) |
13,619 |
0 |
% |
|
| MRSN |
Mersana Therapeutics, Inc... |
VP, Controller |
• – – |
2023-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,352 |
17,194 |
0 |
- |
|
| MRSN |
Mersana Therapeutics, Inc... |
VP, Controller |
• – – |
2023-01-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,784 |
11,842 |
0 |
- |
|
| MRSN |
Mersana Therapeutics, Inc... |
VP, Controller |
• – – |
2022-01-18 |
4 |
S |
$5.92 |
$11,733 |
D/D |
(1,982) |
3,371 |
0 |
% |
|
| MRSN |
Mersana Therapeutics, Inc... |
VP, Controller |
• – – |
2022-01-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,353 |
5,353 |
0 |
- |
|
| MRSN |
Mersana Therapeutics, Inc... |
VP, Controller |
• – – |
2021-07-01 |
4 |
AS |
$13.60 |
$12,811 |
D/D |
(942) |
0 |
0 |
% |
|
| MRSN |
Mersana Therapeutics, Inc... |
VP, Controller |
• – – |
2021-01-19 |
4 |
AS |
$21.28 |
$11,598 |
D/D |
(545) |
0 |
0 |
% |
|
| MRSN |
Mersana Therapeutics, Inc... |
VP, Controller |
• – – |
2021-01-15 |
4 |
D |
$21.09 |
$6,095 |
D/D |
(289) |
545 |
0 |
- |
|
| MRSN |
Mersana Therapeutics, Inc... |
VP, Controller |
• – – |
2021-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
834 |
834 |
0 |
- |
|
| MRSN |
Mersana Therapeutics, Inc... |
VP, Controller |
• – – |
2021-01-04 |
4 |
AS |
$26.76 |
$6,610 |
D/D |
(247) |
0 |
0 |
% |
|
| MRSN |
Mersana Therapeutics, Inc... |
VP, Controller |
• – – |
2020-07-02 |
4 |
AS |
$22.49 |
$76,084 |
D/D |
(3,383) |
0 |
0 |
% |
|
| MRSN |
Mersana Therapeutics, Inc... |
VP, Controller |
• – – |
2020-06-30 |
4 |
AB |
$4.87 |
$16,475 |
D/D |
3,383 |
3,383 |
0 |
% |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
